EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir

Haozhou Tan, Xiang Chi, Xufang Deng iD, Jun Wang iD

ACS Pharmacology & Translational Science · 13.02.2026 · 9 (2) · 404-413

DOI: 10.1021/acsptsci.5c00681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 28.01.2026. Verfasst von Haozhou Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2ensitrelviribuzatrelvirmain proteasenirmatrelvir

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States.
  • Department of Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, Oklahoma 74078, United States.
  • Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma 74078, United States.

ORCID-Profile: Xufang Deng, Jun Wang

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Tan, H., Chi, X., Deng, X., & Wang, J. (2026). Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir. ACS Pharmacology & Translational Science, 9(2), 404-413. https://doi.org/10.1021/acsptsci.5c00681

Vancouver

Tan H, Chi X, Deng X, Wang J. Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir. ACS Pharmacology & Translational Science. 2026;9(2):404-413. doi:10.1021/acsptsci.5c00681

BibTeX
@article{Tan2026,
  author = {Tan, Haozhou and Chi, Xiang and Deng, Xufang and Wang, Jun},
  title = {Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir},
  journal = {ACS Pharmacology & Translational Science},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {404--413},
  doi = {10.1021/acsptsci.5c00681}
}
Kostenlos starten →